Swiss pharmaceuticals giant Roche Holding AG yesterday said that US authorities had given it emergency clearance for a test identifying patients most at risk of a dangerous immune response to coronavirus infection.
Some of those worst affected display a severe inflammatory response to COVID-19, as the body tries to fight the infection, but ends up also destroying healthy tissue and even organs such as the kidneys with life-threatening implications.
Extremely ill patients require mechanical ventilation, putting a huge burden on medical teams and resources over many weeks.
Roche said its test would help doctors get a head start before COVID-19 inflammation takes hold as they assess their caseloads to identify priority patients and their treatment options.
“The US Food and Drug Administration has issued an Emergency Use Authorization for the Elecsys IL-6 [interleukin 6] test,” Roche said in a statement.
“This test measures levels of the biomarker [IL-6] and can be used to help identify patients with confirmed COVID-19 disease who could be at high risk of intubation with mechanical ventilation,” it said.
“The test can support physicians, in combination with other examinations and vital signs, to decide early on if a patient with confirmed COVID-19 illness requires mechanical ventilation,” it said.
Tobias Herold, with the Emergency Department at LMU University Hospital in Munich, Germany, said the tests can be carried out on existing, widely available Roche systems and can provide “results in approximately 18 minutes, with a test throughput of up to 300 tests per hour, depending on the analyzer.”
Nissan Motor Co has agreed to sell its global headquarters in Yokohama for ￥97 billion (US$630 million) to a group sponsored by Taiwanese autoparts maker Minth Group (敏實集團), as the struggling automaker seeks to shore up its financial position. The acquisition is led by a special purchase company managed by KJR Management Ltd, a Japanese real-estate unit of private equity giant KKR & Co, people familiar with the matter said. KJR said it would act as asset manager together with Mizuho Real Estate Management Co. Nissan is undergoing a broad cost-cutting campaign by eliminating jobs and shuttering plants as it grapples
TEMPORARY TRUCE: China has made concessions to ease rare earth trade controls, among others, while Washington holds fire on a 100% tariff on all Chinese goods China is effectively suspending implementation of additional export controls on rare earth metals and terminating investigations targeting US companies in the semiconductor supply chain, the White House announced. The White House on Saturday issued a fact sheet outlining some details of the trade pact agreed to earlier in the week by US President Donald Trump and Chinese President Xi Jinping (習近平) that aimed to ease tensions between the world’s two largest economies. Under the deal, China is to issue general licenses valid for exports of rare earths, gallium, germanium, antimony and graphite “for the benefit of US end users and their suppliers
PERSISTENT RUMORS: Nvidia’s CEO said the firm is not in talks to sell AI chips to China, but he would welcome a change in US policy barring the activity Nvidia Corp CEO Jensen Huang (黃仁勳) said his company is not in discussions to sell its Blackwell artificial intelligence (AI) chips to Chinese firms, waving off speculation it is trying to engineer a return to the world’s largest semiconductor market. Huang, who arrived in Taiwan yesterday ahead of meetings with longtime partner Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), took the opportunity to clarify recent comments about the US-China AI race. The Nvidia head caused a stir in an interview this week with the Financial Times, in which he was quoted as saying “China will win” the AI race. Huang yesterday said
Dutch chipmaker Nexperia BV’s China unit yesterday said that it had established sufficient inventories of finished goods and works-in-progress, and that its supply chain remained secure and stable after its parent halted wafer supplies. The Dutch company suspended supplies of wafers to its Chinese assembly plant a week ago, calling it “a direct consequence of the local management’s recent failure to comply with the agreed contractual payment terms,” Reuters reported on Friday last week. Its China unit called Nexperia’s suspension “unilateral” and “extremely irresponsible,” adding that the Dutch parent’s claim about contractual payment was “misleading and highly deceptive,” according to a statement
RSS